Which of the following is true with regard to pharmacological management of ALS?

Question

Quizplus · Accepted Answer

The glutamate inhibitor Riluzole (Rilutek)is approved for the treatment of ALS and may extend survival by several months. While drugs such as Copaxone are effective in treating multiple sclerosis, they have not been found to be effective in treating ALS. Anticonvulsant medications such as Dilantin may be prescribed to manage symptoms of muscle spasticity, but they are not specifically targeting the underlying disease process of ALS. While there is currently no cure for ALS, Riluzole is a medication that has been approved by the FDA for treatment of ALS.

Which of the Following Is True with Regard to Pharmacological